Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Core Viewpoint - Ocugen, Inc. is set to host a conference call and live webcast on March 5, 2025, to discuss its fourth quarter and full year 2024 financial results and provide a business update [1]. Group 1: Company Overview - Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines aimed at improving health and offering hope to patients globally [3]. - The company is advancing a breakthrough modifier gene therapy platform that has the potential to treat multiple retinal diseases with a single product [3]. - Ocugen is also conducting research in infectious diseases and orthopedic diseases to address unmet medical needs [3]. Group 2: Upcoming Events - A pre-market earnings announcement will be issued on the same day as the conference call [2]. - Participants can join the call using specific dial-in numbers for U.S. and international callers, with a conference ID provided [2]. - A replay of the call and archived webcast will be available for approximately 45 days following the event on the Ocugen investor site [2].